source
- Expert outlines sequencing strategies for relapsed/refractory multiple myeloma amid rise of T-cell redirecting therapiesDr. Diana Cirstea, a specialist in multiple myeloma, explained how treatment sequencing is evolving for patients with relapsed or refractory disease. She highlighted that the growing availability o…
- FDA drug division chief Tracy Beth Høeg expected to depart amid leadership shakeupTracy Beth Høeg, who leads the FDA’s Center for Drug Evaluation and Research, is reported to be leaving the agency. Her exit comes shortly after former Commissioner Marty Makary stepped down, sugg…